• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Iso-osmolar Iodixanol Is Better than Low-osmolar Contrast for CIN Prevention. And Then?等渗碘克沙醇在预防造影剂肾病方面优于低渗造影剂。那又如何呢？
Korean Circ J. 2021 Feb;51(2):182-184. doi: 10.4070/kcj.2021.0003.
2
Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients.等渗与低渗对比剂对低风险患者的肾毒性相当。
Clin Nephrol. 2006 Nov;66(5):322-30. doi: 10.5414/cnp66322.
3
Recent clinical trials of iodixanol.碘克沙醇近期的临床试验。
Rev Cardiovasc Med. 2003;4 Suppl 5:S43-50.
4
Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials.等渗碘克沙醇与非离子型低渗对比剂的肾毒性比较：随机对照试验的荟萃分析
Radiology. 2009 Jan;250(1):68-86. doi: 10.1148/radiol.2501080833.
5
Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty.碘克沙醇与碘佛醇在预防糖尿病患者冠脉造影或经皮冠状动脉介入治疗后对比剂肾病中的比较。
Rev Esp Cardiol. 2009 Dec;62(12):1373-80. doi: 10.1016/s1885-5857(09)73531-5.
6
Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials.等渗与低渗对比剂在糖尿病患者中对比诱导肾病的Meta 分析：全文前瞻性、随机对照试验。
PLoS One. 2018 Mar 20;13(3):e0194330. doi: 10.1371/journal.pone.0194330. eCollection 2018.
7
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.离子型低渗与非离子型等渗对比剂在慢性肾衰竭患者血管成形术后避免肾功能恶化的比较：ICON（离子型与非离子型对比剂在慢性肾衰竭患者血管成形术后避免肾功能恶化的研究）。
JACC Cardiovasc Interv. 2009 May;2(5):415-21. doi: 10.1016/j.jcin.2009.03.007.
8
Iodixanol versus low-osmolar contrast media for prevention of contrast induced nephropathy: meta-analysis of randomized, controlled trials.碘克沙醇与低渗造影剂预防造影剂肾病的比较：随机对照试验的荟萃分析。
Circ Cardiovasc Interv. 2010 Aug;3(4):351-8. doi: 10.1161/CIRCINTERVENTIONS.109.917070. Epub 2010 Jul 20.
9
Contrast-induced acute kidney injury in patients with renal dysfunction undergoing a coronary procedure and receiving non-ionic low-osmolar versus iso-osmolar contrast media.肾功能障碍患者行冠状动脉介入治疗时使用非离子型低渗与等渗对比剂对比剂致急性肾损伤的研究
Am J Med Sci. 2010 Jan;339(1):25-30. doi: 10.1097/MAJ.0b013e3181c06e70.
10
Iodixanol versus iopromide in cancer patients: Evidence from a randomized clinical trial.碘克沙醇与碘普罗胺用于癌症患者：一项随机临床试验的证据。
J Cell Physiol. 2018 Mar;233(3):2572-2580. doi: 10.1002/jcp.26132. Epub 2017 Sep 12.

本文引用的文献

1
Contrast Induced Nephropathy and 2-Year Outcomes of Iso-Osmolar Compared with Low-Osmolar Contrast Media after Elective Percutaneous Coronary Intervention.择期经皮冠状动脉介入治疗后等渗与低渗对比剂所致对比剂肾病及2年预后
Korean Circ J. 2021 Feb;51(2):174-181. doi: 10.4070/kcj.2020.0307.
2
Contrast-Associated Acute Kidney Injury and Serious Adverse Outcomes Following Angiography.造影检查后对比剂相关急性肾损伤与严重不良结局
J Am Coll Cardiol. 2020 Mar 24;75(11):1311-1320. doi: 10.1016/j.jacc.2020.01.023.
3
Procedural Strategies to Reduce the Incidence of Contrast-Induced Acute Kidney Injury During Percutaneous Coronary Intervention.降低经皮冠状动脉介入治疗期间造影剂诱导的急性肾损伤发生率的手术策略
JACC Cardiovasc Interv. 2019 Oct 14;12(19):1877-1888. doi: 10.1016/j.jcin.2019.04.055. Epub 2019 Sep 11.
4
Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy.大剂量瑞舒伐他汀负荷剂量对经皮冠状动脉介入治疗后对比剂肾病的影响。
Korean Circ J. 2014 Sep;44(5):301-6. doi: 10.4070/kcj.2014.44.5.301. Epub 2014 Sep 25.
5
N-acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Narrative Review.N-乙酰半胱氨酸预防对比剂肾病：叙事性综述。
Korean Circ J. 2011 Dec;41(12):695-702. doi: 10.4070/kcj.2011.41.12.695. Epub 2011 Dec 31.
6
Viscosity of contrast media perturbs renal hemodynamics.造影剂的粘度会扰乱肾脏血流动力学。
J Am Soc Nephrol. 2007 Nov;18(11):2912-20. doi: 10.1681/ASN.2006111216. Epub 2007 Oct 17.
7
Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial.肾功能不全患者行冠状动脉造影时威视派克（碘克沙醇）与六溴环已胺（碘克沙葡胺）的肾毒性评估及比较：RECOVER研究：一项随机对照试验
J Am Coll Cardiol. 2006 Sep 5;48(5):924-30. doi: 10.1016/j.jacc.2006.06.047. Epub 2006 Aug 17.
8
Pathophysiology of contrast medium-induced nephropathy.造影剂诱发肾病的病理生理学
Kidney Int. 2005 Jul;68(1):14-22. doi: 10.1111/j.1523-1755.2005.00377.x.
9
Contrast nephropathy: review focusing on prevention.对比剂肾病：聚焦于预防的综述
J Am Coll Cardiol. 2004 Nov 2;44(9):1763-71. doi: 10.1016/j.jacc.2004.06.075.
10
Nephrotoxic effects in high-risk patients undergoing angiography.血管造影高危患者的肾毒性作用。
N Engl J Med. 2003 Feb 6;348(6):491-9. doi: 10.1056/NEJMoa021833.

Iso-osmolar Iodixanol Is Better than Low-osmolar Contrast for CIN Prevention. And Then?

作者信息

Jo Sang Ho

机构信息

Division of Cardiology, Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.

出版信息

Korean Circ J. 2021 Feb;51(2):182-184. doi: 10.4070/kcj.2021.0003.

DOI:10.4070/kcj.2021.0003
PMID:33525074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7853893/
Abstract
摘要